Manesar ramp-up slower than expected
The greenfield facility posted an operating loss of INR 12-13 crore in Q3; any delay in reaching break-even could pressure margins.
medium · management_commentary
Fortis Healthcare Limited — Q3 FY25
Fortis Healthcare delivered a strong Q3 FY25 with consolidated revenue of INR 1,928 crore (+14.8% YoY) and EBITDA of INR 375 crore (+32% YoY), driven by the hospital business wh...
bullish
high
✓ Verified against BSE filing
Risk Intelligence
Material risks this quarter
Concise cards keep the risk register scannable while preserving evidence-level context in the underlying quarter data.
Risks
Agilus growth recovery may lag
Despite guidance, Agilus revenue growth has been sluggish (3.5% YoY) and rebranding costs may persist, delaying margin improvement.
medium · analyst_questionLegal costs and open offer uncertainty
Ongoing legal cases related to the open offer and forensic audit could result in elevated legal expenses and management distraction.
medium · analyst_questionCompetitive intensity in hospital expansion
Aggressive bed additions by peers and potential talent wars could pressure occupancy and margins, though management downplays near-term impact.
low · analyst_question